ARTA
GNCA

A.R.T. Advisors’s Genocea Biosciences, Inc. GNCA Stock Holding History

A.R.T. Advisors’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6,202
Closed -$38K – 1862
2018
Q3 		$38K Sell
6,202
-6,927
-53% -$36.6K ﹤0.01% 1329
2018
Q2 		$89K Sell
13,129
-10,076
-43% -$75.4K ﹤0.01% 1301
2018
Q1 		$194K Buy
23,205
+1,688
+8% +$14K 0.01% 1275
2017
Q4 		$199K Buy
+21,517
New +$216K 0.01% 1168
2014
Q3 		– Sell
-1,384
Closed -$207K – 1645
2014
Q2 		$207K Buy
+1,384
New +$210K 0.01% 1124

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

A.R.T. Advisors's GNCA Position: Q4 2018 in Review

A.R.T. Advisors sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2018, closing a stake of 6,202 shares — an estimated $38K sold.

A.R.T. Advisors first reported a position in GNCA in Q2 2014 and held it in 5 quarters. The position peaked at $207K in Q2 2014. 43 funds tracked by Wall St. Rank hold GNCA as of Q4 2018.

  • A.R.T. Advisors reported no remaining Genocea Biosciences, Inc. position as of Q4 2018 after selling out during the quarter.
  • A.R.T. Advisors sold 6,202 Genocea Biosciences, Inc. shares in Q4 2018, an estimated $38K.
  • A.R.T. Advisors first reported a position in Genocea Biosciences, Inc. in Q2 2014 and held it in 5 quarters.
  • A.R.T. Advisors's Genocea Biosciences, Inc. position peaked at $207K in Q2 2014.
  • 43 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2018.

Based on A.R.T. Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.